Market Samachar
Home  ›  INDIAN
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
NDTV PROFIT - LATEST · INDIAN ·

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

As reported by NDTV Profit - Latest
Emcure's combination of a diversified domestic franchise, scalable international platforms, proven M&A execution and multiple complex -product opportunities offer a stronger and more diversified growth profile, adds the brokerage.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar